We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$254B
AUM Growth
+$235B
Cap. Flow
+$230B
Cap. Flow %
90.52%
Top 10 Hldgs %
17.14%
Holding
3,268
New
2,228
Increased
916
Reduced
59
Closed
11

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$8.24B
2
AAPL icon
Apple
AAPL
+$6.76B
3
AMZN icon
Amazon
AMZN
+$6.52B
4
META icon
Meta Platforms (Facebook)
META
+$4.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.45B

Sector Composition

Rank Sector Weight
1 Technology 18.97%
2 Financials 14.46%
3 Healthcare 12.78%
4 Consumer Discretionary 10.65%
5 Industrials 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SB icon
2676
Safe Bulkers
SB
$774M
$1.15M ﹤0.01%
+736,880
New +$1.14M
UUUU icon
2677
Energy Fuels
UUUU
$3.53B
$1.15M ﹤0.01%
+367,106
New +$1.11M
AGEN
2678
Agenus
AGEN
$290M
$1.15M ﹤0.01%
+19,505
New +$1.07M
LXRX icon
2679
Lexicon Pharmaceuticals
LXRX
$1.1B
$1.15M ﹤0.01%
+182,203
New +$1.09M
BBAR icon
2680
BBVA Argentina
BBAR
$3.49B
$1.14M ﹤0.01%
+101,063
New +$943K
SPOK icon
2681
Spok Holdings
SPOK
$241M
$1.14M ﹤0.01%
+76,086
New +$1.13M
EBTC
2682
DELISTED
Enterprise Bancorp
EBTC
$1.14M ﹤0.01%
+35,976
New +$1.07M
BFST icon
2683
Business First Bancshares
BFST
$1.03B
$1.14M ﹤0.01%
+44,730
New +$1.11M
NVS icon
2684
Novartis
NVS
$297B
$1.13M ﹤0.01%
12,423
-1,864
-13% -$158K
NERV icon
2685
Minerva Neurosciences
NERV
$199M
$1.13M ﹤0.01%
+25,051
New +$1.25M
SFST icon
2686
Southern First Bancshares
SFST
$600M
$1.13M ﹤0.01%
+28,819
New +$1.04M
BXC icon
2687
BlueLinx
BXC
$706M
$1.13M ﹤0.01%
+56,903
New +$1.3M
ACNB icon
2688
ACNB Corp
ACNB
$655M
$1.12M ﹤0.01%
+28,416
New +$1.07M
DCPH
2689
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$1.12M ﹤0.01%
+49,708
New +$1.16M
FMAO icon
2690
Farmers & Merchants Bancorp
FMAO
$481M
$1.12M ﹤0.01%
+38,476
New +$1.15M
VSLR
2691
DELISTED
VIVINT SOLAR, INC.
VSLR
$1.11M ﹤0.01%
+151,903
New +$960K
CDMO
2692
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$1.11M ﹤0.01%
+197,580
New +$815K
GBLI icon
2693
Global Indemnity Group
GBLI
$1.1M ﹤0.01%
+35,664
New +$1.08M
MCBC
2694
DELISTED
Macatawa Bank Corp
MCBC
$1.1M ﹤0.01%
+107,579
New +$1.12M
GLRE icon
2695
Greenlight Captial
GLRE
$506M
$1.1M ﹤0.01%
+129,488
New +$1.33M
TGH
2696
DELISTED
Textainer Group Holdings limited
TGH
$1.1M ﹤0.01%
+109,003
New +$1.07M
LCTX icon
2697
Lineage Cell Therapeutics
LCTX
$278M
$1.1M ﹤0.01%
+998,149
New +$1.15M
FTR
2698
DELISTED
Frontier Communications Corp.
FTR
$1.09M ﹤0.01%
625,923
+388,897
+164% +$793K
CATO icon
2699
Cato Corp
CATO
$66.1M
$1.09M ﹤0.01%
+88,737
New +$1.21M
HIVE
2700
DELISTED
Aerohive Networks
HIVE
$1.09M ﹤0.01%
+246,515
New +$891K

Similar funds

Nuveen's Q2 2019 Portfolio in Review

As of Q2 2019, Nuveen held 3,268 positions worth $254B, up 1,256% from $18.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Nuveen deployed $230B of net new capital in Q2 2019, opening 2,228 new positions and adding to 916 existing holdings. Its largest new stake was Netflix: 33,941,080 shares worth $1.25B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $142M trimmed.

  • Nuveen's largest Q2 2019 buy was Netflix: 33,941,080 shares worth $1.25B.
  • Nuveen added most to Microsoft in Q2 2019, an estimated $8.24B increase.
  • Nuveen's biggest Q2 2019 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $142M.
  • Nuveen fully exited Nuveen ESG Large-Cap Value ETF in Q2 2019, selling an estimated $22M.
  • Nuveen's ten largest holdings make up 17% of its $254B portfolio in Q2 2019.
  • Nuveen opened 2,228 new positions and closed 11 in Q2 2019.
  • Nuveen's portfolio value rose 1,256% quarter-over-quarter to $254B.

Based on Nuveen's 13F filing for Q2 2019, filed 15 Aug 2019.